Colgate-Palmolive Company (NYSE:CL) is included among the 15 Dividend Stocks That Have Increased Payouts for Over 20 Years.
Colgate-Palmolive Company (NYSE:CL) is down nearly 14%, leaving analysts concerned about its prospects.
On October 10, JPMorgan lowered its price target for Colgate-Palmolive Company (NYSE:CL) from $95 to $88, while maintaining an Overweight rating on the stock ahead of the company’s release of third-quarter 2025 results.
The consumer products leader will report its third-quarter results on Friday, October 31, before the market opens. JPMorgan attributed the lowered price target to softer performance across all product categories. Although Colgate-Palmolive Company (NYSE:CL) maintained its full-year 2025 guidance for both revenue and earnings, the company now expects organic sales growth to be at the lower end of its previously projected range of 2% to 4% due to weak category trends.
However, several positive factors have helped balance these headwinds. More favorable foreign exchange conditions have allowed management to reaffirm its outlook for low single-digit net sales growth. Additionally, while tariff-related costs have improved by $125 million, water is not expected to total around $75 million, these savings are largely offset by higher expenditures on raw materials and packaging materials.
Despite these short-term pressures, Colgate-Palmolive Company (NYSE:CL) remains a reliable income stock, as the company has been increasing its dividend for 62 consecutive years. The company offers a quarterly dividend of $0.52 per share for a dividend yield of 2.66%, as of October 16.
While we recognize CL’s potential as an investment, we believe certain AI stocks offer greater growth potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that’s also benefiting significantly from Trump-era tariffs and the offshoring trend, check out our free report on best short-term AI stock.
READ NEXT: 12 Dividend Stocks You Should Buy for Investing and 11 Defensive Healthcare Dividend Stocks to Buy Now.
Disclosure: None.